APA (7th ed.) Citation

Fodil, S., Raffoux, E., Dumas, P. Y., Desbrosses, Y., Larosa, F., Chantepie, S., . . . Frayfer, J. (2021). Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Leukemia & Lymphoma, 62(7), 1756. https://doi.org/10.1080/10428194.2021.1881505

Chicago Style (17th ed.) Citation

Fodil, S., et al. "Data from French Named Patient Program of Quizartinib in Relapsed/refractory Acute Myeloid Leukemia." Leukemia & Lymphoma 62, no. 7 (2021): 1756. https://doi.org/10.1080/10428194.2021.1881505.

MLA (9th ed.) Citation

Fodil, S., et al. "Data from French Named Patient Program of Quizartinib in Relapsed/refractory Acute Myeloid Leukemia." Leukemia & Lymphoma, vol. 62, no. 7, 2021, p. 1756, https://doi.org/10.1080/10428194.2021.1881505.